Publication Name	World Journal of Transplantation
Manuscript ID	39113
Country	United States

Received	2018-03-29 00:51
Peer-Review Started	2018-03-29 08:58
To Make the First Decision	2018-04-11 01:24
Return for Revision	2018-04-13 02:51
Revised	2018-04-22 08:59
Second Decision	2018-06-07 11:54
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-06-09 00:32
Articles in Press	2018-06-09 00:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-08-06 07:24
Publish the Manuscript Online	2018-08-09 08:05

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Minireviews
Article Title	Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	Francis E Dailey, Erica P Turse, Maliha Naseer, Jack D Bragg and Veysel Tahan
ORCID	Author(s) ORCID Number Francis E Dailey http://orcid.org/0000-0001-8353-0709 Erica P Turse http://orcid.org/0000-0003-2270-2305 Maliha Naseer http://orcid.org/0000-0001-6891-1378 Jack D Bragg http://orcid.org/0000-0002-2537-3941 Veysel Tahan http://orcid.org/0000-0001-6796-9359
Funding Agency and Grant Number
Corresponding Author	Veysel Tahan, FACG, FACP, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri Health Center, One Hospital Drive, CD 405, Columbia, MO 65212, United States. tahanv@health.missouri.edu
Key Words	Crohn’s disease; Stem cells; Mesenchymal; Perianal disease; Fistula; Inflammatory bowel disease
Core Tip	Allogeneic and autologous mesenchymal stem cells (MSCs) are being researched for use in patients with refractory perianal Crohn’s disease. Studies from 2003 until now demonstrate efficacy and safety of MSC therapy in this patient population. Up until now, there are no large multi-center, randomized double-blind, placebo-controlled studies examining this.
Publish Date	2018-08-09 08:05
Citation	Dailey FE, Turse EP, Naseer M, Bragg JD, Tahan V. Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease. World J Transplant 2018; 8(4): 97-101
URL	http://www.wjgnet.com/2220-3230/full/v8/i4/97.htm
DOI	http://dx.doi.org/10.5500/wjt.v8.i4.97

Full Article (PDF)	WJT-8-97.pdf
Full Article (Word)	WJT-8-97.doc
Manuscript File	39113-Review.docx
Answering Reviewers	39113-Answering reviewers.pdf
Audio Core Tip	39113-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	39113-Conflict-of-interest statement.pdf
Copyright License Agreement	39113-Copyright license agreement.pdf
Peer-review Report	39113-Peer-review(s).pdf
Scientific Misconduct Check	39113-Scientific misconduct check.pdf
Scientific Editor Work List	39113-Scientific editor work list.pdf